PAR 15.1% 22.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-2581

  1. 6,330 Posts.
    lightbulb Created with Sketch. 572
    ok, fellow holders, sp is up instead of down on a day Morgans downgraded it and got it wrong. Management and our 'resident chemist' did a good job. Onward and upward. This is a great product.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.